Abstract
Intraductal carcinoma (DCIS) was once an uncommon disease. Today, DCIS represents 20-30% of breast cancers that are diagnosed. Mammography has been the gold standard in detecting DCIS, however recent evidence demonstrates that magnetic resonance imaging (MRI) may be superior to mammography in detecting DCIS. In addition, MRI may be able to detect high grade, mammographically occult DCIS that are more likely to progress on to become invasive carcinoma.
Keywords: Breast Cancer, DCIS, Detection, Mammography, MRI
Current Cancer Therapy Reviews
Title:Imaging Intraductal Carcinoma
Volume: 8 Issue: 3
Author(s): Susan Weinstein
Affiliation:
Keywords: Breast Cancer, DCIS, Detection, Mammography, MRI
Abstract: Intraductal carcinoma (DCIS) was once an uncommon disease. Today, DCIS represents 20-30% of breast cancers that are diagnosed. Mammography has been the gold standard in detecting DCIS, however recent evidence demonstrates that magnetic resonance imaging (MRI) may be superior to mammography in detecting DCIS. In addition, MRI may be able to detect high grade, mammographically occult DCIS that are more likely to progress on to become invasive carcinoma.
Export Options
About this article
Cite this article as:
Weinstein Susan, Imaging Intraductal Carcinoma, Current Cancer Therapy Reviews 2012; 8 (3) . https://dx.doi.org/10.2174/157339412802653119
DOI https://dx.doi.org/10.2174/157339412802653119 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
An Aggressive Medical Approach for Inflammatory Bowel Disease: Clinical Challenges and Therapeutic Profiles in a Retrospective Hospitalbased Series
Current Clinical Pharmacology lncRNAs as Potential Targets in Small Cell Lung Cancer: MYC -dependent Regulation
Anti-Cancer Agents in Medicinal Chemistry <i>In Silico</i> Molecular Interaction Studies of Chitosan Polymer with Aromatase Inhibitor: Leads to Letrozole Nanoparticles for the Treatment of Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Clinical Strategies for the Blockade of IL-18 in Inflammatory Bowel Diseases
Current Drug Targets circEPSTI1 Acts as a ceRNA to Regulate the Progression of Osteosarcoma
Current Cancer Drug Targets Anti-Cancer/Anti-Tumor
Current Bioactive Compounds Cytotoxic Constituents from Vietnamese Marine Sponge <i>Haliclona oculata (Linnaeus, 1759)</i>
Letters in Organic Chemistry Two Novel GPER Agonists Induce Gene Expression Changes and Growth Effects in Cancer Cells
Current Cancer Drug Targets Anti-IL-1 β Therapies
Recent Patents on DNA & Gene Sequences Preface
Current Topics in Medicinal Chemistry Effect of Formulations of Nanosized Quercetin Liposomes on COX-2 and NF-kB in MCF-10A Cells
Pharmaceutical Nanotechnology An Orally Bioavailable c-Met Kinase Inhibitor Potently Inhibits Brain Tumor Malignancy and Growth
Anti-Cancer Agents in Medicinal Chemistry Epigenetic control of cardiovascular health by nutritional polyphenols involves multiple chromatin-modifying writer-reader-eraser proteins
Current Topics in Medicinal Chemistry Exploring and Exploiting Microbial Diversity through Metagenomics for Natural Product Drug Discovery
Current Topics in Medicinal Chemistry Loss of the Tumor Suppressor HACE1 Contributes to Cancer Progression
Current Drug Targets Anticancer Drug Combinations, How Far We can Go Through?
Anti-Cancer Agents in Medicinal Chemistry Superoxide Dismutase in Redox Biology: The Roles of Superoxide and Hydrogen Peroxide
Anti-Cancer Agents in Medicinal Chemistry Chronopharmaceutical Delivery of Anti-Inflammatory Drugs
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Systemic Drug Delivery Systems for Bone Tissue Regeneration– A Mini Review
Current Pharmaceutical Design Therapeutic Targeting of G-Protein Coupled Receptor-Mediated Epidermal Growth Factor Receptor Transactivation in Human Glioma Brain Tumors
Mini-Reviews in Medicinal Chemistry